Vaccination strategies for tuberculosis

Abhinav Mehta, Rajeev K. Tyagi, Amit Goyal, Kapil Khatri, Prem N. Gupta, S. P. Vyas

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The widespread plague of tuberculosis (TB) has continued despite the availability of licensed TB vaccine (BCG) and directly observed chemotherapy (DOTS) programmes. Also, emergence of multi-drug resistant strains of Mycobacterium tuberculosis presents serious challenges for the DOTS strategy. Today, TB still remains a deadly disease and leading infectious killer of youth and adults. Clearly, there is a need for an improved TB vaccine. Various efforts have been made in this direction, and a heterologous prime-boost regimen probably represents the best hope for an improved vaccine regimen to prevent TB. The first generation of new vaccines might also complement drug-treatment regimens and be effective against reactivation of TB from the latent state, which would significantly enhance their usefulness.
Original languageEnglish (US)
Pages (from-to)1501-1505
Number of pages5
JournalCurrent Science
Issue number11
StatePublished - Dec 10 2007
Externally publishedYes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-10-12

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Vaccination strategies for tuberculosis'. Together they form a unique fingerprint.

Cite this